𝔖 Bobbio Scriptorium
✦   LIBER   ✦

812 Non-Hodgkin's lymphoma of intermediate degree. 13-year follow-up of 89 patients treated with chop

✍ Scribed by A. Murias; José Aguiar; José Almenarez; F. Molano; U. Bohn; P. Betancor; M. Sosa


Book ID
116167558
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
149 KB
Volume
31
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Long-term follow-up of patients with int
✍ Fausto Rossini; Elisabetta Terruzzi; Daniele Perego; Isabella Miccolis; Franca R 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 1 views

## Abstract ## BACKGROUND Doxorubicin cardiotoxicity is one of the most serious side effects of the cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy, regimen, especially among elderly patients. In the CEOP regimen, epirubicin was substituted for doxorubicin to reduce cardiot

Long-term follow-up of patients receivin
✍ Dr. Raymond H. S. Liang; Edmond K. W. Chiu; T. K. Chan; David Todd; Ronald P. Ng 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 423 KB 👁 1 views

This is an analysis of the long-term follow-up data of 99 patients receiving HOAP-Bleo, IMVP-16 and PAC as salvage chemotherapy for refractory or relapsed intermediate or high grade non-Hodgkin's lymphomas. Most of the patients received HOAP-Bleo or PAC following failure of initial chemotherapy and